← FDA Drug Approvals (Drugs@FDA)
BALVERSA
NDA · New Drug Application · Sponsor: JANSSEN BIOTECH · Approved 2019-04-12
Drug application
- FDA Application #
NDA212018- Application type
- New Drug Application
- Brand name
- BALVERSA
- Generic name
- ERDAFITINIB
- Active ingredients
- ERDAFITINIB
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- JANSSEN BIOTECH
- Manufacturer
- Janssen Products LP
- First approval
- 2019-04-12
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown